A potential role of erythropoietin in angiogenesis associated with myelodysplastic syndromes.
Ribatti
D
D
D004921:Erythropoietin / Q000627:therapeutic use*; D019337:Hematologic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000473:pathology*; D017467:Receptors, Erythropoietin / Q000378:metabolism
D017467:Receptors, Erythropoietin; D004921:Erythropoietin